z-logo
Premium
Dual effect of inorganic polymeric phosphate/polyphosphate on osteoblasts and osteoclasts in vitro
Author(s) -
Wang Xiaohong,
Schröder Heinz C.,
DiehlSeifert Bärbel,
Kropf Klaus,
Schlossmacher Ute,
Wiens Matthias,
Müller Werner E. G.
Publication year - 2013
Publication title -
journal of tissue engineering and regenerative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.835
H-Index - 72
eISSN - 1932-7005
pISSN - 1932-6254
DOI - 10.1002/term.1465
Subject(s) - polyphosphate , chemistry , osteoclast , osteoblast , alkaline phosphatase , in vitro , bone morphogenetic protein 2 , microbiology and biotechnology , biophysics , phosphate , biochemistry , biology , enzyme
Inorganic polymeric phosphate/polyphosphate (polyP) is a natural polymer existing in both pro‐ and eukaryotic systems. In the present study the effect of polyP as well as of polyP supplied in a stoichiometric ratio of 2  m polyP:1  m CaCl 2 [polyP (Ca 2+ complex)] on the osteoblast‐like SaOS‐2 cells and the osteoclast‐like RAW 264.7 cells was determined. Both polymers are non‐toxic for these cells up to a concentration of 100 µ m . In contrast to polyP, polyP (Ca 2+ complex) significantly induced hydroxyapatite formation at a concentration > 10 µ m , as documented by alizarin red S staining and scanning electron microscopic (SEM) inspection. Furthermore, polyP (Ca 2+ complex) triggered in SaOS‐2 cells transcription of BMP2 (bone morphogenetic protein 2), a cytokine involved in maturation of hydroxyapatite‐forming cells. An additional activity of polyP (Ca 2+ complex) is described by showing that this polymer impairs osteoclastogenesis. At concentrations > 10 µ m polyP (Ca 2+ complex) slows down the progression of RAW 264.7 cells to functional osteoclasts, as measured by the expression of TRAP (tartrate‐resistant acid phosphatase). Finally, it is shown that 10–100 µ m polyP (Ca 2+ complex) inhibited phosphorylation of I κ B α by the respective kinase in RAW 264.7 cells. We concluded that polyP (Ca 2+ complex) displays a dual effect on bone metabolizing cells. It promotes hydroxyapatite formation in SaOS‐2 cells (osteoblasts) and impairs maturation of the osteoclast‐related RAW 264.7 cells. Copyright © 2012 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom